Justin Holko | Investor Relations |
Leonard Schleifer | Founder, President & Chief Executive Officer |
George Yancopoulos | Founding Scientist, President & Chief Scientific Officer |
Marion McCourt | Senior Vice President & Head of Commercial |
Bob Landry | Executive Vice President & Chief Financial Officer |
Carter Gould | UBS |
Matthew Harrison | Morgan Stanley |
Terence Flynn | Goldman Sachs |
Yaron Weber | Cowen |
Geoff Porges | SVB Leerink |
Cory Kasimov | JPMorgan |
Evan Seigerman | Credit Suisse |
Yatin Suneja | Guggenheim Partners |
Mohit Bansal | Citigroup |
Kennen MacKay | RBC Capital Markets |
Alethia Young | Cantor Fitzgerald |
Hartaj Singh | Oppenheimer & Co. |
Brian Skorney | Baird |
Welcome to the Regeneron Pharmaceuticals Q2 2019 Earnings Conference Call. My name is John and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session [Operator Instructions] Please note the conference is being recorded.
And I will now turn the call over to Justin Holko.